The key question is whether glucose disposal in people with prediabetes or type 2 diabetes is limited exclusively by impairment in insulin-dependent GLUT4 translocation or insulin-dependent tissue perfusion. This evidence concerns the gene INS and type 2 diabetes mellitus.